81 related articles for article (PubMed ID: 16719202)
21. Frequent occurrence of uniparental disomy in colorectal cancer.
Andersen CL; Wiuf C; Kruhøffer M; Korsgaard M; Laurberg S; Ørntoft TF
Carcinogenesis; 2007 Jan; 28(1):38-48. PubMed ID: 16774939
[TBL] [Abstract][Full Text] [Related]
22. Molecular discrimination of multiple primary versus metastatic squamous cell cancers of the head/neck and lung.
Mercer RR; Lucas NC; Simmons AN; Zander DS; Tsongalis GJ; Funkhouser WK; Coleman WB
Exp Mol Pathol; 2009 Feb; 86(1):1-9. PubMed ID: 19094981
[TBL] [Abstract][Full Text] [Related]
23. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
25. Genetically heterogeneous and clonally unrelated metastases may arise in patients with cutaneous melanoma.
Katona TM; Jones TD; Wang M; Eble JN; Billings SD; Cheng L
Am J Surg Pathol; 2007 Jul; 31(7):1029-37. PubMed ID: 17592269
[TBL] [Abstract][Full Text] [Related]
26. Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer.
Malesci A; Laghi L; Bianchi P; Delconte G; Randolph A; Torri V; Carnaghi C; Doci R; Rosati R; Montorsi M; Roncalli M; Gennari L; Santoro A
Clin Cancer Res; 2007 Jul; 13(13):3831-9. PubMed ID: 17606714
[TBL] [Abstract][Full Text] [Related]
27. [Detection of genetic mutations in clinical specimens from cancer patients: comparison of NIRCA and SSCP scanning methods].
Botezatu IV; Kondratova VN; Cherkes VL; Barsukov IuA; Aliev VE; Shelepov VP; Likhtenshteĭn AV
Vopr Onkol; 2007; 53(5):549-53. PubMed ID: 18154119
[TBL] [Abstract][Full Text] [Related]
28. Phenotypes of invasion in sporadic colorectal carcinomas related to aberrations of the adenomatous polyposis coli (APC ) gene.
Prall F; Weirich V; Ostwald C
Histopathology; 2007 Feb; 50(3):318-30. PubMed ID: 17257127
[TBL] [Abstract][Full Text] [Related]
29. Chemoresponsiveness associated with canonical molecular changes in colorectal adenocarcinomas.
Kim JC; Roh SA; Cho DH; Kim TW; Yoon SN; Kim CW; Yu CS; Kim SY; Kim YS
Anticancer Res; 2009 Aug; 29(8):3115-23. PubMed ID: 19661324
[TBL] [Abstract][Full Text] [Related]
30. K-ras mutation detection in colorectal cancer using the Pyrosequencing technique.
Poehlmann A; Kuester D; Meyer F; Lippert H; Roessner A; Schneider-Stock R
Pathol Res Pract; 2007; 203(7):489-97. PubMed ID: 17629419
[TBL] [Abstract][Full Text] [Related]
31. Tissue preparation for gene expression profiling of colorectal carcinoma: three alternatives to laser microdissection with preamplification.
Croner RS; Guenther K; Foertsch T; Siebenhaar R; Brueckl WM; Stremmel C; Hlubek F; Hohenberger W; Reingruber B
J Lab Clin Med; 2004 Jun; 143(6):344-51. PubMed ID: 15192650
[TBL] [Abstract][Full Text] [Related]
32. High-resolution genotyping of chromosome 8 in colon adenocarcinomas reveals recurrent break point but no gene mutation in the 8p21 region.
Mourra N; Zeitoun G; Portier G; Blanche H; Tubacher E; Gressin L; Flejou JF; Tiret E; Thomas G; Olschwang S
Diagn Mol Pathol; 2008 Jun; 17(2):90-3. PubMed ID: 18382363
[TBL] [Abstract][Full Text] [Related]
33. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
[TBL] [Abstract][Full Text] [Related]
34. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
35. Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions.
Emerson RE; Wang M; Liu F; Lawrence WD; Abdul-Karim FW; Cheng L
Int J Gynecol Pathol; 2007 Oct; 26(4):387-94. PubMed ID: 17885488
[TBL] [Abstract][Full Text] [Related]
36. Loss of Smad4 protein expression and 18qLOH as molecular markers indicating lymph node metastasis in colorectal cancer--a study matched for tumor depth and pathology.
Tanaka T; Watanabe T; Kazama Y; Tanaka J; Kanazawa T; Kazama S; Nagawa H
J Surg Oncol; 2008 Jan; 97(1):69-73. PubMed ID: 17786972
[TBL] [Abstract][Full Text] [Related]
37. [Microsatellite instability of sporadic colorectal carcinomas and its clinicopathological significance].
Xiao XY; Zhou XY; Sun MH; Yan G; Du X
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):289-93. PubMed ID: 16875631
[TBL] [Abstract][Full Text] [Related]
38. [Detection and clinicopathologic significance of microsatellite alteration and p53 mutation of neuroendocrine cells in colorectal adenocarcinoma].
Zhang HY; Wei XL; Wang LL; Zhang BY; Zhao ZS; Lü YB; Yao GY
Zhonghua Bing Li Xue Za Zhi; 2013 Jan; 42(1):10-4. PubMed ID: 23611266
[TBL] [Abstract][Full Text] [Related]
39. Synchronous lung tumours in a patient with metachronous colorectal carcinoma and a germline MSH2 mutation.
Canney A; Sheahan K; Keegan D; Tolan M; Hyland J; Green A
J Clin Pathol; 2009 May; 62(5):471-3. PubMed ID: 19398597
[TBL] [Abstract][Full Text] [Related]
40. Small-cell neuroendocrine carcinoma displays unique profiles of tumor-suppressor gene loss in relationship to the primary site of formation.
Dacic S; Finkelstein SD; Baksh FK; Swalsky PA; Barnes LE; Yousem SA
Hum Pathol; 2002 Sep; 33(9):927-32. PubMed ID: 12378519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
